AKR1C2 抗体
(Aldo-keto Reductase Family 1, Member C2 (AKR1C2))
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| AKR1C2 抗体 (AA 1-123) (Fluoro550) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (AA 1-123) (FITC) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (AA 1-123) (Fluoro488) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (AA 1-123) (PE) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (AA 1-123) (Fluoro647) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (C-Term) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (CF®488A) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®740) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®568) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®647) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®594) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®405S) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (CF®640R) | 人 | 小鼠 Monoclonal |
|
|
|
| AKR1C2 抗体 (AA 1-323) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (Alexa Fluor 555) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
|
| AKR1C2 抗体 (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 1-123
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-123
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 1-123
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 1-123
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 1-123
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 295-323
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- C-Term, AA 295-323
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®488A
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®740
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®568
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®647
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®594
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- Biotin
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®405S
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- CPTC-AKR1C2-1
- 标记
- CF®640R
- 抗体亚型
- IgG2a, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-323
Latest Publications for our AKR1C2 抗体
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 217-26, (2011) (PubMed).
: "Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 36, Issue 6, pp. 991-4, (2008) (PubMed).
: "Aldo-keto reductase 1C2 is essential for 1-nitropyrene's but not for benzo[a]pyrene's induction of p53 phosphorylation and apoptosis." in: Toxicology, Vol. 244, Issue 2-3, pp. 257-70, (2008) (PubMed).
: "Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis." in: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 217-26, (2011) (PubMed).
: "Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 36, Issue 6, pp. 991-4, (2008) (PubMed).
: "Aldo-keto reductase 1C2 is essential for 1-nitropyrene's but not for benzo[a]pyrene's induction of p53 phosphorylation and apoptosis." in: Toxicology, Vol. 244, Issue 2-3, pp. 257-70, (2008) (PubMed).
Aliases for AKR1C2 抗体
aldo-keto reductase family 1 member C2 (AKR1C2) 抗体aldo-keto reductase family 1, member C2 (Akr1c2) 抗体
AKR1C-pseudo 抗体
Akr1c21 抗体
BABP 抗体
DD 抗体
DD2 抗体
DDH2 抗体
HAKRD 抗体
HBAB 抗体
MCDR2 抗体
SRXY8 抗体
您还需要查找其他产品吗？
- AKR1C1 抗体
- AKR1B10 抗体
- AKR1B1 抗体
- AKR1A1 抗体
- AKNA Domain Containing 1 抗体
- AKNA 抗体
- AKIRIN2 抗体
- AKIP1 抗体
- AKAP9 抗体
- AKAP8L 抗体
- AKAP8 抗体
- AKAP7 抗体
- AKAP6 抗体
- AKAP5 抗体
- AKAP4 抗体
- AKAP3 抗体
- AKAP2 抗体
- AKAP14 抗体
- AKAP13 抗体
- AKAP12 抗体
- AKR1C3 抗体
- AKR1C4 抗体
- AKR1D1 抗体
- AKR1E2 抗体
- AKR7A2 抗体
- AKR7A3 抗体
- AKT Interacting Protein 抗体
- AKT2 抗体
- AKT3 抗体
- ALAD 抗体
- Alanine Glyoxylate Aminotransferase 抗体
- Alanyl (Membrane) Aminopeptidase 抗体
- Alanyl-tRNA Synthetase 抗体
- ALAS1 抗体
- ALAS2 抗体
- Albumin 抗体
- Alcohol Dehydrogenase 抗体
- Alcohol Dehydrogenase 7 (Class IV), mu Or sigma Polypeptide 抗体
- Aldehyde Dehydrogenase 抗体
- ALDH16A1 抗体
You are here:
